NOACs Recommended as First-Line Prevention of Stroke in A-Fib
TUESDAY, Jan. 29, 2019 -- For patients with atrial fibrillation, novel oral anticoagulants (NOACs) are recommended over warfarin to prevent stroke and weight loss is recommended for overweight and obese individuals, according to updated guidelines...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Atrial Fibrillation | Coumadin | Eating Disorders & Weight Management | Obesity | Pharmaceuticals | Stroke | Warfarin | Weight Loss